You are here
Dr Henry Nasrallah - Founding Editor-in-Chief of Schizophrenia Research
Dr. Nasrallah’s research focuses on the neurobiology and psychopharmacology of schizophrenia and related psychoses. He has published 380 scientific articles, 440 abstracts, as well as 11 books. He is Editor-In-Chief of two journals (SCHIZOPHRENIA RESEARCH and CURRENT PSYCHIATRY). He has received over 85 research grants and is listed in all editions of the book “Best Doctors in America”. Dr Nasrallah has received research grants from Genentech, Otsuka, Roche and Shire. He has carried out consultancy/advisory work for Boehringer Ingelheim, Genentech, Janssen, Merck, Novartis, Otsuka, Lundbeck, Roche, and Sunovion. He has been a speaker on behalf of Janssen, Merck, Novartis, Otsuka and Sunovion.